Oak Street Health, Cleveland, Ohio.
The University of Toledo College of Medicine and Life Sciences, Toledo, Ohio; and.
Clin J Sport Med. 2023 Mar 1;33(2):e14-e15. doi: 10.1097/JSM.0000000000001093. Epub 2022 Nov 6.
This report highlights a new, patient-centered paradigm for managing post-COVID-19 dysautonomia symptoms during sports and exercise. The patient was a healthcare worker exposed before vaccination. She experienced postural orthostatic tachycardia plus exertional tachycardia, with postexertional fatigue, beginning a few weeks after testing positive for COVID-19. Stress test, echo, and an extensive dysautonomia evaluation were negative. Recommended nonpharmacological and pharmacological interventions were poorly tolerated. Prescription of a novel regimen of "basal-dose" ivabradine, plus very low-dose metoprolol according to an exertional "sliding scale" managed symptoms to an acceptable level for work and recreation.
本报告强调了一种新的、以患者为中心的模式,用于管理 COVID-19 后自主神经功能紊乱症状在运动和锻炼期间。患者是一名在接种疫苗前接触过的医护人员。她出现体位性心动过速伴运动后心动过速,伴有运动后疲劳,在 COVID-19 检测呈阳性后几周开始出现。应激试验、超声心动图和广泛的自主神经功能紊乱评估均为阴性。推荐的非药物和药物干预措施耐受性差。根据运动“滑动量表”,开处方使用新型“基础剂量”伊伐布雷定和非常低剂量美托洛尔的方案,将症状控制在可接受的工作和娱乐水平。